NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/27/2021
Back to search
Official data from USPTO
PIERIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PIERIS
ST13
US500000077638905Class
1, 5, 42
Filing
77638905
Registration
3891767
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
03/27/2021
Trademark type
Word
Nice classes
1, 5, 42
Filing date
12/23/2008
Registration date
12/21/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/27/2021
Last transaction
03/27/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
16
Owner location
Hallbergmoos, DE
Examiner
SHARPER JR, SAM
Law office
L80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PIERIS PHARMACEUTICALS GMBH
PIERIS AG
Representatives
Michael J. Leonard Fox Rothschild LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and scienceconjugates of organic and inorganic chemicals with polypeptidesproteinsartificial polypeptides and artificial proteins produced by genetic engineeringnucleic acid molecule encoding polypeptides and proteins all for scientific and research use; Bio-chemicals and biopharmaceuticalspolypeptidesprotein arraysartificial polypeptides produced by genetic engineeringfor scientific and research useother than medical and veterinary purposes; diagnostic preparations for scientific and research use; diagnostic reagents for scientific and research use; diagnostic preparations for clinical and medical laboratory use and diagnostic reagents for clinical and medical laboratory use
Class 5
Pharmaceuticalveterinary and sanitary preparationsconjugates of organic and inorganic chemicals with polypeptidesproteinsartificial polypeptidesartificial proteins produced by genetic engineeringall for medical purposesmedication for treatment of cancermedication for treatment of auto-immune diseasesmedication for eye diseasesvaccinesmedication for treatment of bacterial infectionsmedication for treatment of fungal infectionmedication for treatment of infectious diseasesmedication for treatment of inflammatory diseasesmedication for viral diseasespain relief medicationmedication for animal skin care and medication for dermatology ; medical diagnostic reagents
Class 42
Research in science and industryresearch in the areas of biochemistrydiagnostics and pharmaceuticals; bio-chemistry or pharmaceutical laboratories; laboratory research in the field of life scienceshealthcare and medicinal researchagro-chemistryveterinary usesenvironmental technologyfood and flavor industryprotein-chip industry
Publications
History of USPTO decisions and trademark events.
48 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/27/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/27/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/27/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
12/15/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/21/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/13/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/13/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/13/2017
E815
TEAS SECTION 8 & 15 RECEIVED
12/06/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/14/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/31/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/21/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/04/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
12/21/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/05/2010
PUBO
PUBLISHED FOR OPPOSITION
10/05/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/01/2010
ALIE
ASSIGNED TO LIE
09/01/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/18/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
08/18/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/18/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
08/18/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/18/2010
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/17/2010
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/15/2010
CHPB
POST PUBLICATION AMENDMENT - ENTERED
08/03/2010
ADBS
1(B) BASIS DELETED; NEW BASIS REQUESTED
07/21/2010
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
07/20/2010
APET
ASSIGNED TO PETITION STAFF
07/14/2010
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/09/2010
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
07/09/2010
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/16/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/16/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
01/26/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2009
PUBO
PUBLISHED FOR OPPOSITION
11/03/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/29/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/24/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2009
ALIE
ASSIGNED TO LIE
09/23/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/22/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/23/2009
GNRT
NON-FINAL ACTION E-MAILED
03/23/2009
CNRT
NON-FINAL ACTION WRITTEN
03/23/2009
DOCK
ASSIGNED TO EXAMINER
03/17/2009
NWAP
NEW APPLICATION ENTERED
12/29/2008
Continuous trademark protection
Get notified about every new filing that threatens PIERIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.